RecruitingNot Applicable

Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)

China800 participantsStarted 2024-01-01

Plain-language summary

Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.

Who can participate

Age range16 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * BMI\>27.5kg/m2; Type 2 diabetes mellitus; Patients who will undergo bariatric surgery Exclusion Criteria: * Patients without abdominal CT scan; Patients did not undergo sleeve gastrectomy or Roux-en-Y gastric bypass.

What they're measuring

Area under curve (AUC) of the weight loss prediction model after 1 year

Timeframe: 1 year

Area under curve (AUC) of the T2DM remission prediction model after 1 year

Timeframe: 1 year

Trial details

NCT IDNCT06169033

SponsorChina-Japan Friendship Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-31

Contact for this trial

Yuntao Nie, M.D.

+8618611835860 nytnyt1231@163.com

View on ClinicalTrials.gov More Obesity trials